全球脊髓刺激設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計脊髓刺激設備市場將從 2025 年的 30.3 億美元成長到 2034 年的 65.1 億美元，2026 年至 2034 年的複合年成長率為 8.86%。

由於慢性疼痛和神經系統疾病的盛行率不斷上升，全球脊髓刺激設備市場正經歷顯著成長。這些設備廣泛用於對傳統治療方法無效的患者的疼痛管理。人們對微創疼痛管理方案的認知不斷提高，推動了患者的接受度。植入式裝置的科技進步正在改善病患的舒適度、安全性和整體治療效果。

推動市場發展的關鍵因素包括全球人口老化、腰痛發病率上升以及人們對非鴉片類鎮痛方案日益成長的偏好。醫療服務提供者擴大推薦脊髓刺激療法作為長期藥物治療的替代方案。更完善的報銷政策和支持性的法規結構也促進了市場擴張。製造商正致力於開發可充電和無線設備，以提高便利性和患者滿意度。

隨著神經調控技術的不斷創新，脊髓刺激設備市場前景依然強勁。設備小型化、電池續航時間和編程功能的提升可望改善臨床療效。發展中地區醫療保健覆蓋範圍的擴大也可能進一步刺激市場需求。隨著全球對慢性疼痛管理日益成長的關注，脊髓刺激設備將在改善患者生活品質方面發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球脊髓刺激設備市場：依適應症分類

• 市場分析、洞察與預測
• Failed Back Surgery Syndrome
• 複雜性局部疼痛症候群
• 退化性椎間盤病變
• 其他

第5章 全球脊髓刺激設備市場：依產品分類

• 市場分析、洞察與預測
• 可充電裝置
• 不可充電設備

第6章：全球脊髓刺激設備市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 其他

第7章 全球脊髓刺激設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Saluda Medical Pty Ltd
  • Nevro Corporation
  • Abbott Laboratories
  • Nalu Medical Inc
  • GIMER MEDICAL
  • Beijing PINS Medical Co. Ltd
  • Teliatry Inc
  • Medtronic Plc
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG

The Spinal Cord Stimulation Devices Market size is expected to reach USD 6.51 Billion in 2034 from USD 3.03 Billion (2025) growing at a CAGR of 8.86% during 2026-2034.

The Global Spinal Cord Stimulation Devices Market is witnessing significant growth due to the increasing prevalence of chronic pain conditions and neurological disorders. These devices are widely used to manage pain that does not respond to conventional treatments. Growing awareness about minimally invasive pain management options is encouraging patient adoption. Technological advancements in implantable devices are improving patient comfort, safety, and overall treatment effectiveness.

Key market drivers include the aging global population, rising incidence of back pain, and increasing preference for non-opioid pain management solutions. Healthcare providers are increasingly recommending spinal cord stimulation as an alternative to long-term medication use. Improved reimbursement policies and supportive regulatory frameworks are also facilitating market expansion. Manufacturers are focusing on developing rechargeable and wireless devices to enhance convenience and patient satisfaction.

Future prospects for the spinal cord stimulation devices market remain strong as innovation continues in neuromodulation technologies. Advances in device miniaturization, battery life, and programming capabilities are expected to enhance clinical outcomes. Expanding healthcare access in developing regions may further boost demand. As the focus on chronic pain management intensifies globally, spinal cord stimulation devices are likely to play a crucial role in improving patients' quality of life.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Indication

• Failed Back Surgery Syndrome
• Complex Regional Pain Syndrome
• Degenerative Disc Disease
• Others

By Product

• Rechargeable Devices
• Non-Rechargeable Devices

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Saluda Medical Pty Ltd, Nevro Corporation, Abbott Laboratories, Nalu Medical Inc, GIMER MEDICAL, Beijing PINS Medical Co Ltd, Teliatry Inc, Medtronic plc, Boston Scientific Corporation, BIOTRONIK SE amp Co KG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET: BY INDICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Indication
• 4.2. Failed Back Surgery Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Complex Regional Pain Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Degenerative Disc Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Rechargeable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Non-Rechargeable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Indication
  • 7.2.2 By Product
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Indication
  • 7.3.2 By Product
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Indication
  • 7.4.2 By Product
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Indication
  • 7.5.2 By Product
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Indication
  • 7.6.2 By Product
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SPINAL CORD STIMULATION DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Saluda Medical Pty Ltd
  • 9.2.2 Nevro Corporation
  • 9.2.3 Abbott Laboratories
  • 9.2.4 Nalu Medical Inc
  • 9.2.5 GIMER MEDICAL
  • 9.2.6 Beijing PINS Medical Co. Ltd
  • 9.2.7 Teliatry Inc
  • 9.2.8 Medtronic Plc
  • 9.2.9 Boston Scientific Corporation
  • 9.2.10 BIOTRONIK SE & Co. KG